Selective targeting of GARP-LTGFβ axis in the tumor microenvironment augments PD-1 blockade via enhancing CD8+ T cell antitumor immunity.
Li A, Chang Y, Song NJ, Wu X, Chung D, Riesenberg BP, Velegraki M, Giuliani GD, Das K, Okimoto T, Kwon H, Chakravarthy KB, Bolyard C, Wang Y, He K, Gatti-Mays M, Das J, Yang Y, Gewirth DT, Ma Q, Carbone D, Li Z.
Li A, et al. Among authors: yang y.
J Immunother Cancer. 2022 Sep;10(9):e005433. doi: 10.1136/jitc-2022-005433.
J Immunother Cancer. 2022.
PMID: 36096533
Free PMC article.